文献速递泌尿生殖腹部USMR

联合PI-RADS v2.1与超声造影的列线图在前列腺癌诊断中减少不必要穿刺的潜力

The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics.
PubMed 文献 · Br J Radiol · 2022-08-17

本研究纳入490例PSA 4-10 ng/ml并接受前列腺穿刺的患者,随机分为建模队列(70%)和验证队列(30%),构建基于年龄、PI-RADS v2.1评分和超声造影表现的列线图预测前列腺癌和临床有意义前列腺癌。建模队列AUC分别为0.843和0.876,验证队列为0.818和0.857,列线图使前列腺癌的不必要穿刺率从74.8%降至21.1%,临床有意义前列腺癌从83.7%降至5.4%。

要点

  • 基于年龄、PI-RADS v2.1评分和超声造影表现的列线图可预测PSA 4-10 ng/ml患者的前列腺癌和临床有意义前列腺癌。
  • 建模队列AUC:前列腺癌0.843、临床有意义前列腺癌0.876;验证队列分别为0.818和0.857。
  • 列线图使不必要穿刺率从前列腺癌的74.8%降至21.1%,临床有意义前列腺癌从83.7%降至5.4%。

核心结论

  • 基于年龄、PI-RADS v2.1和超声造影的列线图预测模型对前列腺癌和临床有意义前列腺癌具有良好预测效能,可用于估算个体患者的前列腺癌风险,从而做出合理的穿刺选择。

研究设计与样本

  • 共纳入490例因PSA 4-10 ng/ml接受前列腺穿刺的患者,随机分为建模队列(70%)和验证队列(30%),构建单因素和多因素逻辑回归模型并建立列线图,采用受试者工作特征曲线下面积(AUC)评估并作DeLong检验,采用Hosmer-Lemeshow拟合优度检验评估模型拟合。

诊断标准与关键数值

  • 多因素分析显示与前列腺癌和临床有意义前列腺癌独立相关的因素为年龄、PI-RADS评分和超声造影表现;列线图AUC在建模队列前列腺癌为0.843、临床有意义前列腺癌为0.876,在验证队列前列腺癌为0.818、临床有意义前列腺癌为0.857;列线图诊断效能与包含全部参数的模型相当(p > 0.05);列线图使不必要穿刺率在前列腺癌从74.8%降至21.1%,在临床有意义前列腺癌从83.7%降至5.4%。

临床应用与阅片要点

  • 作者认为该列线图可估算个体患者的前列腺癌风险,从而做出合理的穿刺选择;本研究旨在通过PI-RADS v2.1和超声造影改善PSA「灰区」男性的穿刺前风险分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To develop a nomogram prediction model based on Prostate Imaging Reporting and Data System v.2.1 (PI-RADS v2.1) and contrast-enhanced ultrasound (CEUS) for predicting prostate cancer (PCa) and clinically significant prostate cancer (csPCa) in males with prostate-specific antigen (PSA) 4-10 ng ml-1 to avoid unnecessary biopsy.

METHODS: A total of 490 patients who underwent prostate biopsy for PSA 4-10 ng ml-1 were enrolled and randomly divided into a pilot cohort (70%) and a validation cohort (30%). Univariate and multivariate logistic regression models were constructed to select potential predictors of PCa and csPCa, and a nomogram was created. The area under receiver operating characteristic (ROC) curve (AUC) was calculated, and compared using DeLong's test. The diagnostic performance and unnecessary biopsy rate of the nomogram prediction model were also assessed. Hosmer-Lemeshow goodness-of-fit test was employed to test for model fitness.

RESULTS: The multivariate analysis revealed that features independently associated with PCa and csPCa were age, PI-RADS score and CEUS manifestations. Incorporating these factors, the nomogram achieved good discrimination performance of AUC 0.843 for PCa, 0.876 for csPCa in the pilot cohort, and 0.818 for PCa, 0.857 for csPCa in the validation cohort, respectively, and had well-fitted calibration curves. And the diagnostic performance of the nomogram was comparable to the model including all the parameters (p > 0.05). Besides, the nomogram prediction model yielded meaningful reduction in unnecessary biopsy rate (from 74.8 to 21.1% in PCa, and from 83.7 to 5.4% in csPCa).

CONCLUSIONS: The nomogram prediction model based on age, PI-RADS v2.1 and CEUS achieved an optimal prediction of PCa and csPCa. Using this model, the PCa risk for an individual patient can be estimated, which can lead to a rational biopsy choice.

ADVANCES IN KNOWLEDGE: This study gives an account of improving pre-biopsy risk stratification in males with "gray zone" PSA level through PI-RADS v2.1 and CEUS.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Liu, Wang, Xiang, et al. The potential of a nomogram combined PI-RADS v2.1 and contrast-enhanced ultrasound (CEUS) to reduce unnecessary biopsies in prostate cancer diagnostics. Br J Radiol. 2022. PMID: 35877385. doi:10.1259/bjr.20220209

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。